Sign in

CIK 0001833214

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

SAB Biotherapeutics, Inc.

Sign in to watch
Ticker
SABS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
853899721
Phone
+1 305-845-2813
Business address
777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
Former names
Big Cypress Acquisition Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-03-16 Luke Thomas Charles Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +20,519 20,519
2021-10-22 Luke Thomas Charles Chief Medical Officer Grant or award +5,428 5,428
2021-10-22 Luke Thomas Charles Chief Medical Officer Grant or award · Earnout Rights (Common Stock) +2,193 2,193
2021-10-22 Luke Thomas Charles Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +139,585 139,585
2021-10-22 Luke Thomas Charles Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +11,632 11,632
2021-10-22 Luke Thomas Charles Chief Medical Officer Grant or award · Earnout Rights (Restricted Stock Units) +61,092 61,092
2021-10-19 Luke Thomas Charles Chief Medical Officer Grant or award +990 $10.10 $10K 990

Page 1 of 1 · 7 trades